Literature DB >> 8260594

Elevated levels of TNF in the joints of adjuvant arthritic rats.

T Smith-Oliver1, L S Noel, S S Stimpson, D P Yarnall, K M Connolly.   

Abstract

The primary purpose of this study was to determine whether local levels of tumor necrosis factor (TNF) were elevated in chronically inflamed joints in rats with adjuvant-induced arthritis (AA). We also wished to develop methodology for the quantitative measurement of joint TNF, and to examine the effects of known anti-inflammatory agents on joint TNF levels. TNF levels were measured in joints from AA rats taken during the systemic phase (day 20) of arthritic disease. Using the L929 bioassay, joint extracts from AA rats had significantly greater TNF levels (1054 +/- 147 pg/g tissue) than joint extracts from normal rats (110 +/- 42 pg/g tissue). Administration of ibuprofen failed to significantly inhibit TNF levels in the joint at a time point when paw swelling was significantly reduced. The immunomodulating agents, methotrexate, cyclosporin A (CSA) and HWA486 profoundly inhibited both joint TNF levels and paw swelling. The specificity of this assay for TNF was supported by studies with a polyclonal rabbit anti-mouse TNF antibody which neutralized 78-87% of the TNF activity in the joint extracts. Our studies demonstrate a quantitative increase in local TNF expression in adjuvant arthritis and support a role for TNF in chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260594     DOI: 10.1016/1043-4666(93)90060-i

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  21 in total

1.  Anti-inflammatory and anti-arthritic effects of 3-hydroxy, 2-methoxy sodium butanoate from the leaves of Clerodendrum phlomidis L.f.

Authors:  N Prakash Babu; S Saravanan; P Pandikumar; K Bala Krishna; M Karunai Raj; S Ignacimuthu
Journal:  Inflamm Res       Date:  2013-11-08       Impact factor: 4.575

2.  Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression.

Authors:  M F Neurath; K Hildner; C Becker; J F Schlaak; K Barbulescu; T Germann; E Schmitt; P Schirmacher; S Haralambous; M Pasparakis; K H Meyer Zum Büschenfelde; G Kollias; E Märker-Hermann
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis.

Authors:  S J Oliver; S L Freeman; L G Corral; C J Ocampo; G Kaplan
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

4.  Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis.

Authors:  Daisuke Tanaka; Takashi Kagari; Hiromi Doi; Takaichi Shimozato
Journal:  Immunology       Date:  2006-07-12       Impact factor: 7.397

Review 5.  Role of cytokines in experimental arthritis.

Authors:  F M Brennan
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis.

Authors:  A C Issekutz; A Meager; I Otterness; T B Issekutz
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Calcineurin inhibitors exert rapid reduction of inflammatory pain in rat adjuvant-induced arthritis.

Authors:  Katsue Magari; Susumu Miyata; Yoshitaka Ohkubo; Seitaro Mutoh; Toshio Goto
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  Effect of leflunomide on immunological liver injury in mice.

Authors:  Hong-Wei Yao; Jun Li; Yong Jin; Yun-Fang Zhang; Chang-Yu Li; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment.

Authors:  I Rioja; K A Bush; J B Buckton; M C Dickson; P F Life
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.

Authors:  L Sekut; D Yarnall; S A Stimpson; L S Noel; R Bateman-Fite; R L Clark; M F Brackeen; J A Menius; K M Connolly
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.